脑部放疗，上午比下午敏感许多！( W, l8 c! t* s/ N3 ^
6 u% H, Z$ @1 W3 D' G
% ~: ~: X' ]# E2 c& X( `$ ICancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
9 e' b3 n2 X" y* c3 sGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
2 L6 q. b$ T3 F& `' S3 N. R* ]2 q9 PRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.) Y% c$ \* B; k, G. {
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
2 N: ?( L9 ]! L' t |$ P3 |0 D2 ^2 d( J0 v s1 K$ s% f
Abstract, e) S, F3 G- V0 T3 r; T9 I
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
0 T! }1 H* Y; a2 Y3 D4 S3 ?; Q
5 H5 D% Y" }" V1 I6 L* Q) Q \+ b( [METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
3 b. g2 q" o5 c
0 b. R) m8 {0 w( W5 N+ X5 V. `RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).$ z0 M, E: b( C; }0 ]6 L' c
# W7 L* S; t+ L, yCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
5 I. U/ L% A# n+ @. G4 A! ]
* X, l% r7 c5 Q: u. r* U% e |
( l) \+ l( \" C- Y4 y9 q
显身卡
